GGrantIndex
← Leaderboards

Alexander A Soukas

Massachusetts General Hospital

$11,713,503
Attributed
$11,713,503
Total exposure
13
Grants
13
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $2.1M · FY200725
$2.5M$1.9M$1.3M$625K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$13,878,165 · 14

By mechanism

R01$7,029,448 · 3
P30$4,729,441 · 6
R56$993,461 · 2
K08$800,820 · 1
R03$174,000 · 1
F32$150,995 · 1

Top collaborators

No co-investigators on record.

Most similar at Massachusetts General Hospital

Same institution · by research overlap

Others in their field

Top investigators on “Pathway Interactions

Research focus

Pathway InteractionsLaboratoriesGenomicsGenesDiabetes MellitusCaenorhabditis ElegansMitochondriaMetabolicGeneticMolecularCellsGrowthPhenotypeMetabolismLongevityMediatingMetabolomicsMemberComplexInnovationResearch PersonnelGenome EditingGenerationsAnimals

Grant awards (41)

Metabolic Phenotyping Core$228,602
P30 · FY2025 · DK · contact PI
Boston Area Diabetes and Endocrinology Research Center (BADERC)$1,073,972
P30 · FY2024 · DK · contact PI
Mitochondrial action of metformin in aging and longevity$420,000
R01 · FY2024 · AG · contact PI
P&F program$307,810
P30 · FY2024 · DK · contact PI
Metabolic Phenotyping Core$228,602
P30 · FY2024 · DK · contact PI
Boston Area Diabetes and Endocrinology Research Center (BADERC)$1,090,690
P30 · FY2023 · DK · contact PI
Mitochondrial action of metformin in aging and longevity$420,000
R01 · FY2023 · AG · contact PI
Admin Core$356,019
P30 · FY2023 · DK · contact PI
Metabolic Phenotyping Core$228,602
P30 · FY2023 · DK · contact PI
Genetic mechanisms of metformin's pro-longevity and anti-cancer effects$564,433
R01 · FY2022 · AG · contact PI
Mitochondrial action of metformin in aging and longevity$420,000
R01 · FY2022 · AG · contact PI
Autophagy and Mitochondrial Permeability in Aging and Longevity$344,400
R56 · FY2022 · AG · contact PI
Metabolic Phenotyping Core$262,602
P30 · FY2022 · DK · contact PI
Genetic mechanisms of metformin's pro-longevity and anti-cancer effects$564,432
R01 · FY2021 · AG · contact PI
Mitochondrial action of metformin in aging and longevity$420,000
R01 · FY2021 · AG · contact PI
Metabolic Phenotyping Core$183,408
P30 · FY2021 · DK · contact PI
Regulation of autophagy and mitochondrial permeability by target of rapamycin complex 2$649,061
R56 · FY2020 · AG · contact PI
Genetic mechanisms of metformin's pro-longevity and anti-cancer effects$564,432
R01 · FY2020 · AG · contact PI
Mitochondrial action of metformin in aging and longevity$420,000
R01 · FY2020 · AG · contact PI
Metabolic Phenotyping Core$183,408
P30 · FY2020 · DK · contact PI
Genetic mechanisms of metformin's pro-longevity and anti-cancer effects$562,208
R01 · FY2019 · AG · contact PI
Metabolic Phenotyping Core$186,696
P30 · FY2019 · DK · contact PI
Genetic mechanisms of metformin's pro-longevity and anti-cancer effects$142,800
R01 · FY2019 · AG · contact PI
Genetic mechanisms of metformin's pro-longevity and anti-cancer effects$590,293
R01 · FY2018 · AG · contact PI
Epigenetic regulation of metabolism by target of rapamycin complex 2$388,170
R01 · FY2018 · DK · contact PI
Metabolic Phenotyping Core$190,640
P30 · FY2018 · DK · contact PI
Epigenetic regulation of metabolism by target of rapamycin complex 2$388,170
R01 · FY2017 · DK · contact PI
Metabolic Phenotyping Core$208,390
P30 · FY2017 · DK · contact PI
Epigenetic regulation of metabolism by target of rapamycin complex 2$388,170
R01 · FY2016 · DK · contact PI
Epigenetic regulation of metabolism by target of rapamycin complex 2$388,170
R01 · FY2015 · DK · contact PI
Epigenetic regulation of metabolism by target of rapamycin complex 2$388,170
R01 · FY2014 · DK · contact PI
Obesity and diabetes genetics in Caenorhabditis elegans.$160,164
K08 · FY2014 · DK · contact PI
Dissecting the molecular mechanism of metformin action$87,000
R03 · FY2014 · DK · contact PI
Obesity and diabetes genetics in Caenorhabditis elegans.$160,164
K08 · FY2013 · DK · contact PI
Dissecting the molecular mechanism of metformin action$87,000
R03 · FY2013 · DK · contact PI
Obesity and diabetes genetics in Caenorhabditis elegans.$160,164
K08 · FY2012 · DK · contact PI
Obesity and diabetes genetics in Caenorhabditis elegans.$160,164
K08 · FY2011 · DK · contact PI
Obesity and diabetes genetics in Caenorhabditis elegans.$160,164
K08 · FY2010 · DK · contact PI
Obesity and diabetes genetics and therapeutics in Caenorhabditis elegans.$43,255
F32 · FY2009 · DK · contact PI
Obesity and diabetes genetics and therapeutics in Caenorhabditis elegans.$54,842
F32 · FY2008 · DK · contact PI
Obesity and diabetes genetics and therapeutics in Caenorhabditis elegans.$52,898
F32 · FY2007 · DK · contact PI